학술논문

Brentuximab vedotin with dacarbazine or nivolumab as frontline cHL therapy for older patients ineligible for chemotherapy
Document Type
Article
Source
In Blood 29 February 2024 143(9):786-795
Subject
Clinical Trials and Observations
Lymphoid Neoplasia
Language
ISSN
0006-4971